Clinical Trials Directory

Trials / Completed

CompletedNCT05314855

Brain Clock and Insulin Resistance

Role of the Central Brain Clock in the Pathophysiology of Insulin Resistance

Status
Completed
Phase
Study type
Observational
Enrollment
28 (actual)
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Academic / Other
Sex
All
Age
25 Years – 65 Years
Healthy volunteers
Accepted

Summary

In this observational cohort study the investigators will determine the activity rhythm of the suprachiasmatic nucleus in humans with progressive stages of insulin resistance, using advanced functional brain imaging (7 Tesla functional MRI).

Detailed description

Type 2 diabetes mellitus (T2DM) has an increasing worldwide incidence. Insulin resistance is a key pathophysiological process in the development of hyperglycemia in patients with T2DM. Disruption of circadian synchrony leads to insulin resistance. Animal studies and post-mortem human brain studies suggest that the master brain clock in the hypothalamic suprachiasmatic nucleus (SCN) plays a role in the development of insulin resistance. Up to now, no-one has investigated whether the in vivo activity rhythm of the SCN is affected in patients with insulin resistance. The investigators hypothesize that the master brain clock has an important role in the development of human insulin resistance.

Conditions

Interventions

TypeNameDescription
DEVICEfunctional MRISubjects will undergo functional MRI at 4 time points in 24 hours.

Timeline

Start date
2023-01-04
Primary completion
2025-01-18
Completion
2025-11-01
First posted
2022-04-06
Last updated
2026-01-07

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT05314855. Inclusion in this directory is not an endorsement.